Apogee Therapeutics, Inc. (APGE)
135.07
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 16:00
Apogee Therapeutics Cash and Short Term Investments (Annual) : 730.19M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 730.19M |
| December 31, 2024 | 520.65M |
| Date | Value |
|---|---|
| December 31, 2023 | 395.46M |
| December 31, 2022 | 151.89M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Cogent Biosciences, Inc. | 900.76M |
| Arrowhead Pharmaceuticals, Inc. | 919.37M |
| Intellia Therapeutics, Inc. | 449.88M |
| Revolution Medicines, Inc. | 2.026B |
| Erasca, Inc. | 276.08M |